1-(RS)-1-[4-Hydroxy-3-(Hydroxymethylphenyl]-2-[(4-phenylbutyl)aminoethanol (Salmeterol EP Impurity A)(CAS: 1798014-51-3)

Salmeterol EP Impurity A (CAS: 1798014-51-3) is subject to regulatory guidelines such as GHS classification for hazardous materials, REACH regulations in the EU, and FDA/EPA requirements in the United States. It is essential to follow these guidelines for proper handling, storage, and disposal.

In the synthesis of Salmeterol EP Impurity A (CAS: 1798014-51-3), alternatives such as other impurities or isomers can be considered. Common substitutes include 1-(RS)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]-2-[(3-phenylpropyl)amino]ethanol or 1-(RS)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]-2-[(2-phenylethyl)amino]ethanol, which can serve as similar structural analogs.

The market trend for Salmeterol EP Impurity A (CAS: 1798014-51-3) reflects a focus on quality control and regulatory compliance in the pharmaceutical industry. Emerging research is increasingly emphasizing the development of safer and more effective alternatives to ensure patient safety and compliance with international standards.

Waste containing Salmeterol EP Impurity A (CAS: 1798014-51-3) should be collected and disposed of in accordance with local and international regulations. Proper waste management includes incineration or professional waste disposal services, with precautions to prevent environmental contamination and ensure safety during handling.